Your Client Rank:
Loading...
99
Updated 29-Nov-2023
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Lilly | 17.4% | 0.6% | -8.1% | -14.1% | 19.3% | -8.2% | 42.1% | 42.7% |
| Novo | 16.7% | 0.1% | -0.8% | 0.8% | 1.7% | 0.4% | 17.3% | 17.9% |
| Daiichi | 13.1% | 1.9% | -0.4% | -6.4% | 23.9% | 10.0% | 35.2% | 35.3% |
| Vertex | 8.2% | 0.5% | 0.5% | -4.8% | 3.6% | 1.1% | 11.7% | 11.6% |
| Astra | 7.6% | -0.1% | -3.6% | -1.3% | 5.7% | 2.2% | 12.8% | 12.7% |
| Eisai | 7.2% | 0.3% | -1.8% | -3.6% | 17.7% | -5.8% | 26.6% | 25.9% |
| Regeneron | 5.8% | 0.1% | -2.0% | -0.9% | 0.2% | 1.7% | 6.5% | 6.0% |
| Merck | 5.4% | 1.5% | -2.4% | -20.1% | 45.6% | -19.7% | 68.9% | 70.3% |
| Sanofi | 5.4% | 1.2% | -3.0% | -0.5% | 4.9% | 2.4% | 6.5% | 6.8% |
| Amgen | 5.0% | -0.3% | 0.9% | -0.1% | -0.3% | 0.2% | 4.5% | 5.5% |
| Astellas | 4.9% | -0.1% | -4.0% | -0.2% | 17.7% | 1.2% | 24.1% | 21.1% |
| Glaxo | 3.9% | 0.0% | -0.7% | -0.1% | 3.9% | 2.9% | 5.5% | 4.8% |
| AbbVie | 3.8% | 0.2% | -1.0% | -1.5% | 1.8% | 0.4% | 6.4% | 6.7% |
| Roche | 3.8% | 0.2% | -0.9% | 0.5% | 1.7% | 1.0% | 6.5% | 6.5% |
| Biogen | 3.3% | 2.0% | -2.7% | -5.1% | 9.9% | 0.8% | 13.8% | 14.6% |
| JnJ | 2.8% | -0.1% | -0.4% | -0.1% | 0.7% | 1.1% | 2.8% | 4.8% |
| Novartis | 2.8% | 0.5% | -1.8% | -0.4% | 1.4% | 0.3% | 6.8% | 7.6% |
| Gilead | 2.7% | -0.1% | -1.4% | -2.8% | 2.0% | 4.2% | 4.2% | 4.6% |
| Pfizer | 2.6% | 5.9% | -3.9% | -2.7% | 25.7% | 6.5% | 22.9% | 23.4% |
| Lundbeck | 2.4% | 1.1% | -1.4% | 0.4% | 6.7% | 0.0% | 10.5% | 9.7% |
| Chugai | 1.9% | 2.3% | 4.2% | 1.8% | 3.4% | 0.2% | 5.4% | 5.1% |
| Bayer | 1.8% | 3.8% | | 0.9% | | | 3.9% | 5.8% |
| Takeda | 1.4% | 0.3% | -0.9% | 0.7% | 21.0% | 98.4% | 1.7% | 32.9% |
| Shionogi | 0.2% | 0.3% | -3.2% | -1.2% | 2.8% | 0.4% | 2.4% | 3.4% |
| Teva | 0.1% | 0.7% | 0.0% | 2.5% | 2.6% | 3.8% | 5.5% | 4.7% |
| Viatris | -0.1% | -6.6% | | | | | 1.7% | 2.9% |
| Bristol | -0.5% | -0.4% | 0.7% | 0.9% | -1.0% | 0.7% | -3.2% | -1.7% |
| EU Major | 5.7% | 1.0% | -1.1% | -0.2% | 4.1% | 0.2% | 9.1% | 8.1% |
| Other EU | 2.4% | 1.1% | -1.4% | 0.4% | 6.7% | 0.0% | 10.5% | 9.7% |
| US Major | 4.8% | 1.3% | -2.4% | -8.1% | 10.4% | -1.9% | 15.4% | 18.8% |
| US Big Biotech | 4.6% | 0.2% | -1.1% | -2.2% | 1.9% | 1.8% | 6.6% | 8.1% |
| Other US | 0.0% | -2.9% | 0.0% | 2.6% | 2.7% | 3.8% | 3.4% | 3.7% |
| Japanese | 4.6% | 0.9% | -0.6% | -1.1% | 13.3% | 4.1% | 10.1% | 14.3% |
